Publications:

PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Ilic, Nina N; Utermark, Tamara T; Widlund, Hans R HR; Roberts, Thomas M TM

Publication Date: 2011-09-13

Variant appearance in text: PIK3CA: I848V

PubMed Link: 21876152

Variant Present in the following documents:

• Main text

View BVdb publication page

Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 alpha.

Cancer Cell

Zunder, Eli R ER; Knight, Zachary A ZA; Houseman, Benjamin T BT; Apsel, Beth B; Shokat, Kevan M KM

Publication Date: 2008-08-12

Variant appearance in text: PI3K: I848V

PubMed Link: 18691552

Variant Present in the following documents:

• Main text

View BVdb publication page